• Login
    View Item 
    •   SMARTech Home
    • Georgia Tech Theses and Dissertations
    • Georgia Tech Theses and Dissertations
    • View Item
    •   SMARTech Home
    • Georgia Tech Theses and Dissertations
    • Georgia Tech Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Polyvalent vaccines and therapeutics against viral pathogens

    Thumbnail
    View/Open
    ROSEN-DISSERTATION-2017.pdf (2.293Mb)
    Date
    2017-08-02
    Author
    Rosen, Tania
    Metadata
    Show full item record
    Abstract
    Viral infections caused by HIV or influenza viruses have killed millions of people worldwide. Currently available drugs against such viruses do combat the infections to some extent but are not the best long-term solutions; drug toxicity, drug resistance and viral persistence are just some of the issues that are yet to be overcome. In this work, the concept of polyvalency was used to design viral inhibitors and vaccines. For the first part of my thesis, a universal vaccine has been developed by controlling the antigen (hemagglutinin) presentation to the immune system to enhance the accessibility of the conserved epitopes in the stalk. In preliminary in-vivo challenge experiments with a chimeric H5/1N1 virus, the hemagglutinin (head biotin)-nanotube conjugates (proposed vaccine) showed better protection than controls. We have subsequently expressed biotinylated hemagglutinin using baculoviral infection of insect cells and have optimized the purification scheme by adding a size exclusion chromatography step after the affinity chromatography step. For the second part of my thesis, polyvalent influenza therapeutics have been designed based on ‘hemagglutinin binding’ proteins that bind to conserved epitopes. We demonstrated that the dimers of both the HB proteins studied were more effective at inhibiting the binding of stalk-binding antibodies to hemagglutinin than the corresponding HB monomers. For the third part of my thesis, we designed polyvalent molecules that bind to multiple sites on HIV co-receptor, CCR5 (C-C chemokine receptor, type 5). We synthesized homodimeric, heterodimeric and multimeric versions of Leukotoxin E (LukE) (a CCR5-binding protein) and characterized their ability to inhibit the binding of a gp120-CD4 fusion protein (called FLSC) to CCR5+ 293T cells as compared to that of Leukotoxin E alone.
    URI
    http://hdl.handle.net/1853/58755
    Collections
    • Georgia Tech Theses and Dissertations [23877]
    • School of Chemical and Biomolecular Engineering Theses and Dissertations [1516]

    Browse

    All of SMARTechCommunities & CollectionsDatesAuthorsTitlesSubjectsTypesThis CollectionDatesAuthorsTitlesSubjectsTypes

    My SMARTech

    Login

    Statistics

    View Usage StatisticsView Google Analytics Statistics
    facebook instagram twitter youtube
    • My Account
    • Contact us
    • Directory
    • Campus Map
    • Support/Give
    • Library Accessibility
      • About SMARTech
      • SMARTech Terms of Use
    Georgia Tech Library266 4th Street NW, Atlanta, GA 30332
    404.894.4500
    • Emergency Information
    • Legal and Privacy Information
    • Human Trafficking Notice
    • Accessibility
    • Accountability
    • Accreditation
    • Employment
    © 2020 Georgia Institute of Technology